Evolving Pharma Events in a Digital Healthcare Landscape
The vast majority of healthcare providers (HCPs) – 96% – report that they would see benefits from attending more virtual meetings, conferences, and CME events1. As life sciences adapts to a world where the majority of HCPs are digital natives, the traditional cornerstones of HCP engagement are evolving. And these changes are set to create significant benefits for the industry, as well as HCPs: virtual events generate cost savings and reduce risk by eliminating reportable logistical and transportation costs. Creating the right mix of physical and virtual events allows companies to increase reach while focusing their efforts on the most important face-to-face events.
However, companies are now attempting to reimagine engagement strategies that have grown increasingly complex over time. Traditional event and speaker program management has siloed critical functions, leading to compliance challenges and an uncoordinated HCP experience.
The new model in life sciences is to unify information that silos lead to disjointed processes that impact pharma event execution.
Today, the gold standard for life sciences is a hybrid model of physical and virtual events that are fully integrated into the overall HCP experience. Historically, events have not been seen as a dedicated channel in their own right—a core component of multichannel strategy. Why is it so difficult to bring events out of their silo? How can companies accelerate their adoption of a unified event management model?
The Future of Life Sciences Events provides a guide to navigating the changing commercial landscape to deliver more valuable events. Learn how industry leaders are bringing all types of events together for greater visibility and better execution.
1Healthcare IT News, “On24, MedData Group Study Reveals Physician Behavior.”